{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:04:27Z","timestamp":1793426667576,"version":"4.5.0"},"update-to":[{"DOI":"10.1002\/14651858.cd003075.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T00:00:00Z","timestamp":1386115200000}}],"reference-count":126,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003075.pub3","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T22:27:29Z","timestamp":1386196049000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of hypertension in peripheral arterial disease"],"prefix":"10.1002","volume":"2013","author":[{"given":"Deirdre A","family":"Lane","sequence":"first","affiliation":[{"name":"University of Birmingham Centre for Cardiovascular Sciences, City Hospital; Dudley Road Birmingham UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[{"name":"University of Birmingham Centre for Cardiovascular Sciences, City Hospital; Dudley Road Birmingham UK B18 7QH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,12,4]]},"reference":[{"issue":"9","key":"10.1002\/14651858.CD003075.pub3-BIB0001|cit1","first-page":"354","article-title":"Doxazosin and hydrochlorothiazide equally affect arterial wall thickness in hypertensive males with hypercholesterolaemia (the DAPHNE study). Doxazosin Atherosclerosis Progression Study in Hypertensives in the Netherlands","volume":"60","author":"Hoogerbrugge","year":"2002","journal-title":"Netherlands Journal of Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1097\/HJH.0b013e3283471151","article-title":"Effect of nebivolol vs. hydrochlorothiazide on the walking capacity in hypertensive patients with intermittent claudication","volume":"29","author":"Diehm","year":"2011","journal-title":"Journal of Hypertension"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ehj.2003.10.033","article-title":"Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease","volume":"25","author":"Ostergren","year":"2004","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0004|cit4","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large simple randomised trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","author":"The HOPE Study Investigators","year":"1996","journal-title":"Canadian Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1056\/NEJM200001203420302","article-title":"Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: Findings from the INternational VErapamil-SR\/Trandolapril STudy","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"issue":"21","key":"10.1002\/14651858.CD003075.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1001\/jama.290.21.2805","article-title":"A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolspril Study (INVEST): A randomised controlled trial","volume":"290","author":"Pepine","year":"2003","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/S0735-1097(98)00423-9","article-title":"Rationale and design of the International Verapamil SR\/Trandolapril Study (INVEST): An internet-based randomised trial in coronary artery disease patients with hypertension","volume":"32","author":"Pepine","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1161\/HYPERTENSIONAHA.110.169169","article-title":"\u03b2-blockers in patients with intermittent claudication and arterial hypertension: Results from the nebivolol or metoprolol in arterial occlusive disease trial","volume":"58","author":"Espinola-Klein","year":"2011","journal-title":"Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0002-9343(94)90022-1","article-title":"ACE-inhibition with perindopril in essential hypertensive patients with concomitant diseases. The Perindopril Therapeutic Safety Collaborative Research Group","volume":"97","author":"Overlack","year":"1994","journal-title":"American Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0735-1097(98)00100-4","article-title":"Effect of high dose verapamil on restenosis after peripheral angioplasty","volume":"31","author":"Schweizer","year":"1998","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"10.1002\/14651858.CD003075.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00392-010-0184-0","article-title":"Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease","volume":"99","author":"Zankl","year":"2010","journal-title":"Clinical Research in Cardiology"},{"issue":"10","key":"10.1002\/14651858.CD003075.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJM199803053381003","article-title":"The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension","volume":"338","author":"Estacio","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0197-2456(95)00154-9","article-title":"Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial","volume":"17","author":"Estacio","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.0000049640.46039.52","article-title":"Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes","volume":"107","author":"Mehler","year":"2003","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/HJH.0b013e3282f8e3b6","article-title":"Reduced arterial stiffness may contribute to angiotensin-converting enzyme inhibitor induced improvements in walking time in peripheral arterial disease patients","volume":"26","author":"Ahimastos","year":"2008","journal-title":"Journal of Hypertension"},{"issue":"9","key":"10.1002\/14651858.CD003075.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.7326\/0003-4819-144-9-200605020-00009","article-title":"Brief communication: ramipril markedly improves walking ability in patients with peripheral arterial disease: a randomized trial","volume":"144","author":"Ahimastos","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1161\/01.HYP.0000168945.44069.aa","article-title":"Ramipril reduces large-artery stiffness in peripheral arterial disease and promotes elastogenic remodeling in cell culture","volume":"45","author":"Ahimastos","year":"2005","journal-title":"Hypertension"},{"issue":"9489","key":"10.1002\/14651858.CD003075.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","article-title":"Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial","volume":"366","author":"Dahl\u00f6f","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/00004872-200106000-00020","article-title":"Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators","volume":"19","author":"Sever","year":"2001","journal-title":"Journal of Hypertension"},{"issue":"11","key":"10.1002\/14651858.CD003075.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/000331978803901103","article-title":"Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound","volume":"39","author":"Bernardi","year":"1988","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.eurheartj.a061440","article-title":"Lack of influence of propranolol and metoprolol on walking distance in patients with chronic intermittent claudication","volume":"4","author":"Bogaert","year":"1983","journal-title":"European Heart Journal"},{"issue":"3 Pt 1","key":"10.1002\/14651858.CD003075.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/000331978603700302","article-title":"The effect of beta-blockade on leg blood flow in hypertensive patients with intermittent claudication","volume":"37","author":"Bostrom","year":"1986","journal-title":"Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0025|cit25","first-page":"21","article-title":"Double-blind randomized controlled trial of ifenprodil tartrate versus placebo in chronic arterial occlusive disease of the legs at stage II of the Leriche and Fontaine classification","volume":"20","author":"Branchereau","year":"1995","journal-title":"Journal des Maladies Vasculaires"},{"issue":"12 Pt 2","key":"10.1002\/14651858.CD003075.pub3-BIB0026|cit26","first-page":"2113","article-title":"Study population and treatment titration in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT)","volume":"16","author":"Brown","year":"1998","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00044011-199700131-00017","article-title":"Antihypertensive efficacy of amlodipine and enalapril and effects on peripheral blood flow in patients with essential hypertension and intermittent claudication","volume":"13 Suppl 1","author":"Casiglia","year":"1997","journal-title":"Clinical Drug Investigation"},{"issue":"10","key":"10.1002\/14651858.CD003075.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1177\/000331978904001004","article-title":"Clinical efficacy of picotamide in long-term treatment of intermittent claudication","volume":"40","author":"Coto","year":"1989","journal-title":"Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0029|cit29","first-page":"133","article-title":"A comparative trial of ketanserin and nifedipine in hypertension and obstructive peripheral arteriopathy","volume":"8","author":"Coto","year":"1991","journal-title":"Advances in Therapy"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000176008","article-title":"The effects of tertatolol on lipid profile","volume":"83 Suppl 1","author":"Diehm","year":"1993","journal-title":"Cardiology"},{"issue":"23","key":"10.1002\/14651858.CD003075.pub3-BIB0031|cit31","first-page":"1062","article-title":"Multicentre double blind study concerning flunarizine versus placebo in patients with cerebral and peripheral circulatory disorders","volume":"28","author":"Domschky","year":"1977","journal-title":"Medizinische Welt"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0032|cit32","first-page":"13","article-title":"Influence of the calcium antagonist nisoldipin on the sympathetic activity and the energy metabolism at rest and during walking stress in patients with peripheral arterial of the legs and healthy control subjects [Abstract only]","volume":"76 Suppl 2","author":"Gastmann","year":"1987","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1161\/01.CIR.72.6.1226","article-title":"Effect of beta-adrenergic blockers on the peripheral circulation in patients with peripheral vascular disease","volume":"72","author":"Hiatt","year":"1985","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD003075.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"509","DOI":"10.5694\/j.1326-5377.1982.tb124145.x","article-title":"Beta-adrenergic blockade and peripheral vascular disease","volume":"1","author":"Ingram","year":"1982","journal-title":"Medical Journal of Australia"},{"issue":"23","key":"10.1002\/14651858.CD003075.pub3-BIB0035|cit35","first-page":"1050","article-title":"Flunarizine versus placebo in patients with circulatory disorders of the lower extremities: double blind study","volume":"28","author":"Jageneau","year":"1977","journal-title":"Medizinische Welt"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0036|cit36","first-page":"570","article-title":"The alpha and beta blocker carvediol in the treatment of hypertensive patients with POAD","volume":"15","author":"Kalus","year":"1995","journal-title":"Clinical Hemorheology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0037|cit37","first-page":"70","article-title":"Comparative studies of the effect of a cardioselective and a noncardioselective beta-blocker on peripheral circulation in patients with arterial occlusive disease","volume":"98","author":"Klieber","year":"1986","journal-title":"Weiner Klinische Wochenschrift"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0038|cit38","first-page":"288","article-title":"Medical treatment of occlusive arterial disease of the legs. Walking exercise and medically induced hypertension","volume":"6","author":"Larsen","year":"1969","journal-title":"Angiologica"},{"issue":"8","key":"10.1002\/14651858.CD003075.pub3-BIB0039|cit39","first-page":"987","article-title":"Haemodynamic effects of chronic treatment by cilazapril in normotensive patients with obliterative arterial disease of the lower limbs","volume":"87","author":"Laurent","year":"1994","journal-title":"Archives des Maladies du Coeur et des Vaisseaux"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00003246-199505000-00011","article-title":"Invasive haemodynamic evaluation of sublingual captopril and nifedipine in patients with arterial hypertension after abdominal aortic surgery","volume":"23","author":"Leeman","year":"1995","journal-title":"Critical Care Medicine"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1475-097X.1983.tb00696.x","article-title":"Effect of long term beta-adrenergic-blockade on calf blood flow in hypertensive patients","volume":"3","author":"Lepantalo","year":"1983","journal-title":"Clinical Physiology"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1475-097X.1984.tb00803.x","article-title":"Walking capacity of patients with intermittent claudication during chronic antihypertensive treatment with metoprolol and methyldopa","volume":"4","author":"Lepantalo","year":"1984","journal-title":"Clinical Physiology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0044|cit43","first-page":"1","article-title":"Beta blockade and intermittent claudication","volume":"700","author":"Lepantalo","year":"1985","journal-title":"Acta Medica Scandinavica. Supplementum"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0045|cit44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/clpt.1985.3","article-title":"Chronic effects of labetolol, pindolol and propranolol on calf blood flow in intermittent claudication","volume":"37","author":"Lepantalo","year":"1985","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0043|cit45","first-page":"135","article-title":"Adrenoreceptor blocking drugs and cold feet in intermittent claudication","volume":"15","author":"Lepantalo","year":"1986","journal-title":"Vasa"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0954-6820.1985.tb08821.x","article-title":"Does beta-blockade provoke intermittent claudication?","volume":"218","author":"Lepantalo","year":"1985","journal-title":"Acta Medica Scandinavica"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0047|cit47","first-page":"72","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events. Results of the ONTARGET trial [Russian]","volume":"48","author":"Liakishev","year":"2008","journal-title":"Kardiologiia"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/00005344-199606000-00004","article-title":"A dose-effect study of beraprost sodium in intermittent claudication","volume":"27","author":"Lievre","year":"1996","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"7 Part 1","key":"10.1002\/14651858.CD003075.pub3-BIB0049|cit49","first-page":"705","article-title":"The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group","volume":"10","author":"Dahl\u00f6f","year":"1997","journal-title":"American Journal of Hypertension"},{"issue":"9311","key":"10.1002\/14651858.CD003075.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1358863X9700200103","article-title":"Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease","volume":"2","author":"Liu","year":"1997","journal-title":"Vascular Medicine"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/080370598437394","article-title":"The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design","volume":"7","author":"Mann","year":"1998","journal-title":"Blood Pressure"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0053|cit53","first-page":"339","article-title":"Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multi-centre trial","volume":"38","author":"Natali","year":"1989","journal-title":"Annales de Cardiologie et d'Angeiologie"},{"issue":"29-30","key":"10.1002\/14651858.CD003075.pub3-BIB0054|cit54","first-page":"1175","article-title":"Trial of the activity of Sibelium (flunarizine) in circulatory disorders","volume":"29","author":"Nelson","year":"1978","journal-title":"Medizinische Welt"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0055|cit55","first-page":"229","article-title":"Effects of chronic administration of selective betablockers on peripheral circulation of the lower limbs in patients with essential hypertension","volume":"4","author":"Novo","year":"1985","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0056|cit56","first-page":"199","article-title":"Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs","volume":"6","author":"Novo","year":"1986","journal-title":"International Journal of Clinical Pharmacology Research"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0057|cit57","first-page":"169","article-title":"Effects of captopril and ticlopidine, alone or in combination, in hypertensive patients with intermittent claudication","volume":"15","author":"Novo","year":"1996","journal-title":"International Angiology"},{"issue":"12","key":"10.1002\/14651858.CD003075.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","article-title":"Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial\/Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET\/TRANSCEND) Trials","volume":"121","author":"Bohm","year":"2010","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD003075.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.amjcard.2009.07.018","article-title":"Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial (ONTARGET)","volume":"104","author":"Cowan","year":"2009","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ahj.2004.03.020","article-title":"Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial\/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET\/TRANSCEND) trials","volume":"148","author":"Teo","year":"2004","journal-title":"American Heart Journal"},{"issue":"15","key":"10.1002\/14651858.CD003075.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD003075.pub3-BIB0062|cit62","first-page":"1763","article-title":"Telmisartan, ramipril, or both in high-risk Chinese patients: analysis of ONTARGET China data","volume":"124","author":"Yu","year":"2011","journal-title":"Chinese Medical Journal"},{"issue":"2 Pt 1","key":"10.1002\/14651858.CD003075.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0895-7061(01)02048-9","article-title":"Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trial","volume":"15","author":"Kostis","year":"2002","journal-title":"American Journal of Hypertension"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0064|cit64","first-page":"83","article-title":"Efficacy and tolerability of celiprolol and enalapril in patients with essential hypertension","volume":"5","author":"Panzner","year":"1992","journal-title":"Journal of Drug Development"},{"issue":"9627","key":"10.1002\/14651858.CD003075.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/S0140-6736(08)60601-7","article-title":"Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial","volume":"371","author":"POISE study group","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/cpt1975175612","article-title":"Controlled trial of propranolol in intermittent claudication","volume":"17","author":"Reichert","year":"1975","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"8560","key":"10.1002\/14651858.CD003075.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0140-6736(87)92441-X","article-title":"Placebo-controlled comparison of captopril, atenolol, labetalol and pindolol in hypertension complicated by intermittent claudication","volume":"2","author":"Roberts","year":"1987","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0068|cit68","first-page":"631P","article-title":"Double-blind comparison of captopril or nifedipine in hypertension complicated by intermittent claudication","volume":"25","author":"Roberts","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"9","key":"10.1002\/14651858.CD003075.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/000331979204300905","article-title":"Double-blind comparison of captopril with nifedipine in hypertension complicated by intermittent claudication","volume":"43","author":"Roberts","year":"1992","journal-title":"Angiology"},{"issue":"33","key":"10.1002\/14651858.CD003075.pub3-BIB0070|cit70","first-page":"2071","article-title":"Ifenprodil tartrate for the treatment of chronic obliterating arteriosclerosis of the lower limbs with intermittent claudication. A multicentre, prospective, randomised, double-blind trial versus placebo","volume":"65","author":"Rouffy","year":"1989","journal-title":"Semaines des Hopitaux"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0071|cit71","first-page":"193","article-title":"Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?","volume":"85","author":"Schweizer","year":"1996","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0072|cit72","first-page":"43","article-title":"Beta blockers and nitrates in patients with peripheral arterial occlusive disease: long term findings","volume":"26","author":"Schweizer","year":"1997","journal-title":"Vasa"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0073|cit73","first-page":"76","article-title":"Treatment and monitoring of obstructive peripheral arterial disease in elderly with systolic hypertension","volume":"12","author":"Siniscalchi","year":"1993","journal-title":"International Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00005344-198201000-00002","article-title":"Effect of beta-blocking drugs on peripheral blood flow in intermittent claudication","volume":"4","author":"Smith","year":"1982","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"6810","key":"10.1002\/14651858.CD003075.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1136\/bmj.303.6810.1100","article-title":"Beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination","volume":"303","author":"Solomon","year":"1991","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0076|cit76","first-page":"23","article-title":"Angiotensin-converting enzyme inhibition with cilazapril does not improve blood flow, walking time, or plasma lipids in patients with intermittent claudication","volume":"4","author":"Spence","year":"1993","journal-title":"Journal of Vascular Medicine and Biology"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0077|cit77","first-page":"433","article-title":"Flunarizine and cinnarizine in pharmacotherapy of circulatory disturbances","volume":"7","author":"Staessen","year":"1978","journal-title":"Ars Medici Internationaal Tijdschrift voor Praktische Therapie"},{"issue":"17","key":"10.1002\/14651858.CD003075.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"32E","DOI":"10.1016\/0002-9149(93)90950-H","article-title":"A new trial of the efficacy, tolerability and safety of angiotensin-converting enzyme inhibition in mild systemic hypertension with concomitant diseases and therapies. Perindopril Therapeutic Safety Study Group (PUTS)","volume":"71","author":"Stumpe","year":"1993","journal-title":"American Journal of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD003075.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"50E","DOI":"10.1016\/S0002-9149(99)80505-0","article-title":"Vascular wall thickness in hypertension: the Perindopril Regression of Vascular Thickening European Community Trial: PROTECT","volume":"76","author":"Stumpe","year":"1995","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD003075.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/01.STR.26.8.1319","article-title":"Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension","volume":"26","author":"Sutton-Tyrell","year":"1995","journal-title":"Stroke"},{"issue":"s693","key":"10.1002\/14651858.CD003075.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.0954-6820.1985.tb08792.x","article-title":"Is adrenergic betareceptor blockade contraindicated in patients with intermittent claudication?","volume":"217","author":"Svendsen","year":"1985","journal-title":"Acta Medica Scandinavica. Supplementum"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.0954-6820.1986.tb03293.x","article-title":"The effects of acebutolol and metoprolol on walking distances and distal blood pressure in hypertensive patients with intermittent claudication","volume":"219","author":"Svendsen","year":"1986","journal-title":"Acta Medica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0083|cit83","first-page":"351","article-title":"Effects of one-year treatment with calcium channel blocker or angiotensin II receptor blocker on function and stiffness of left ventricle, central and peripheral arteries in patients with essential hypertension","volume":"31","author":"Takeda","year":"2010","journal-title":"Therapeutic Research"},{"issue":"9426","key":"10.1002\/14651858.CD003075.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0140-6736(04)16451-9","article-title":"Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial","volume":"363","author":"Julius","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/080370598437394","article-title":"The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design","volume":"7","author":"Mann","year":"1998","journal-title":"Blood Pressure"},{"issue":"11","key":"10.1002\/14651858.CD003075.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1097\/01.hjh.0000249692.96488.46","article-title":"Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial","volume":"24","author":"Zanchetti","year":"2006","journal-title":"Journal of Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0087|cit87","first-page":"357","article-title":"The influence of chronic treatment with beta-blockade and angiotensin converting enzyme inhibition on the peripheral blood flow in hypertensive patients with and without concomitant intermittent claudication. A comparative cross-over trial","volume":"23","author":"Ven","year":"1994","journal-title":"Vasa"},{"issue":"6","key":"10.1002\/14651858.CD003075.pub3-BIB0088|cit88","first-page":"1058","article-title":"Percutaneous transluminal angioplasty vs reconstructive renovascular surgery in atherosclerotic unilateral renal artery stenosis - a prospective randomised study","volume":"15","author":"Weibull","year":"1992","journal-title":"Journal of Vascular Surgery"},{"issue":"18","key":"10.1002\/14651858.CD003075.pub3-BIB0089|cit89","first-page":"447","article-title":"Behavior of blood pressure and peripheral hemodynamics in interval therapy in untreated and propranolol-treated patients with arterial circulatory disorders of the lower extremities]. [German]","volume":"39","author":"Winterfeld","year":"1984","journal-title":"Zeitschrift fur die Gesamte Innere Medizin und Ihre Grenzgebiete"},{"issue":"5","key":"10.1002\/14651858.CD003075.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jama.2012.216237","article-title":"Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial","volume":"309","author":"Ahimastos","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0091|cit91","first-page":"32","article-title":"Localisation and risk factors of peripheral arterial occlusive disease in the female","volume":"8","author":"Bauwens","year":"1989","journal-title":"International Angiology"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/HYPERTENSIONAHA.109.142240","article-title":"Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: Findings from the INternational VErapamil-SR\/Trandolapril STudy","volume":"55","author":"Bavry","year":"2010","journal-title":"Hypertension"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0093|cit93","first-page":"233","article-title":"Prevalence of peripheral arterial occlusive disease and associated risk factors in a sample of southern Sardinian population","volume":"13","author":"Binaghi","year":"1994","journal-title":"International Angiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1047-2797(96)00148-2","article-title":"Intermittent claudication in 8343 men and 21-year specific mortality follow-up","volume":"7","author":"Bowlin","year":"1997","journal-title":"Annals of Epidemiology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00005344-199219001-00006","article-title":"Different vasodilating mechanisms - different peripheral effects?","volume":"19 Suppl 1","author":"Breckenridge","year":"1992","journal-title":"Journal of Cardiovascular Pharmacology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/PL00013161","article-title":"Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong","volume":"23","author":"Cheng","year":"1999","journal-title":"World Journal of Surgery"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11906-007-0034-2","article-title":"How to treat hypertension in patients with peripheral artery disease","volume":"9","author":"Clement","year":"2007","journal-title":"Current Hypertenssion Reports"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"Criqui","year":"1992","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0099|cit99","first-page":"S1","article-title":"Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC)","volume":"31","author":"Dormandy","year":"2000","journal-title":"Journal of Vascular Surgery"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease","volume":"47","author":"Feringa","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0102|cit102","first-page":"499","article-title":"Surgical treatment for peripheral vascular disease","volume":"5\/6","author":"Fontaine","year":"1954","journal-title":"Helvetica Chirurgica Acta"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.aje.a116294","article-title":"Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study","volume":"135","author":"Fowkes","year":"1992","journal-title":"American Journal of Epidemiology"},{"issue":"9901","key":"10.1002\/14651858.CD003075.pub3-BIB0104|cit104","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0105|cit105","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA"},{"issue":"9B","key":"10.1002\/14651858.CD003075.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"35J","DOI":"10.1016\/S0002-9149(97)00837-0","article-title":"Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period","volume":"80","author":"Hjalmarson","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0108|cit108","first-page":"127","article-title":"The HOPE (Heart Outcomes Prevention Evaluation) Study: the design of a large, simple randomised trial of an angiotensin-converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events","volume":"12","author":"The HOPE Study Investigators","year":"1996","journal-title":"Canadian Journal of Cardiology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2005.09.031","article-title":"Predictors of adverse outcome among patients with hypertension and coronary artery disease","volume":"47","author":"Pepine","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0890-5096(06)60789-9","article-title":"An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease","volume":"2","author":"Johnston","year":"1988","journal-title":"Annals of Vascular Surgery"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0033-0620(74)90034-6","article-title":"Role of blood pressure in cardiovascular morbidity and mortality","volume":"17","author":"Kannel","year":"1974","journal-title":"Progress in Cardiovascular Diseases"},{"issue":"1","key":"10.1002\/14651858.CD003075.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/1358863X9600100111","article-title":"The demographics of claudication and the aging of the American population","volume":"1","author":"Kannel","year":"1996","journal-title":"Vascular Medicine"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jhh.1001209","article-title":"Peripheral vascular disease and hypertension: a forgotten association?","volume":"15","author":"Makin","year":"2001","journal-title":"Journal of Human Hypertension"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/qjmed\/95.4.199","article-title":"Peripheral vascular disease and Virchow's triad for thrombogenesis","volume":"95","author":"Makin","year":"2002","journal-title":"QJM"},{"issue":"7","key":"10.1002\/14651858.CD003075.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1161\/01.ATV.18.7.1108","article-title":"Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"18","author":"McGill","year":"1998","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/aje\/kwi217","article-title":"Temporal trends in the incidence of intermittent claudication from 1950 to 1999","volume":"162","author":"Murabito","year":"2005","journal-title":"American Journal of Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD003075.pub3-BIB0117|cit117","first-page":"218","article-title":"Prevalence of risk factors in patients with peripheral arterial disease. A clinical and epidemiological evaluation","volume":"11","author":"Novo","year":"1992","journal-title":"International Angiology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1001\/archinte.1991.00400090063012","article-title":"Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials","volume":"151","author":"Radack","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.0954-6820.1982.tb01939.x","article-title":"Prevalence of intermittent claudication and its effect on mortality","volume":"211","author":"Reunanen","year":"1982","journal-title":"Acta Medica Scandinavica"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1097\/00005344-198608005-00007","article-title":"Evidence of early changes of the brachial artery circulation in borderline hypertension","volume":"8 Suppl 5","author":"Simon","year":"1986","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ejvs.2008.01.007","article-title":"Management of hypertension in peripheral arterial disease: does the choice of drugs matter?","volume":"35","author":"Singer","year":"2008","journal-title":"European Journal of Vascular and Endovascular Surgery"},{"key":"10.1002\/14651858.CD003075.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.jvs.2006.12.037","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"45 Suppl S","author":"Norgren","year":"2007","journal-title":"Journal of Vascular Surgery"},{"issue":"1-2","key":"10.1002\/14651858.CD003075.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0021-9150(95)05657-2","article-title":"Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study","volume":"120","author":"Violi","year":"1996","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD003075.pub3-BIB0125|cit125","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003075.pub2","article-title":"Treatment of hypertension in peripheral arterial disease","author":"Lane","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD003075.pub3-BIB0126|cit126","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003075","article-title":"Treatment of hypertension in peripheral arterial disease","author":"Lip","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003075.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T10:18:13Z","timestamp":1748341093000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003075.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Vascular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,4]]},"references-count":126,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003075.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,4]]}}}